All In Biotech

Drug Trial Radar · NCT06940141

Rademikibart Add-on Treatment of an Acute Asthma Exacerbation (Seabreeze STAT Asthma)

A Phase 2, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Rademikibart as an Add-on Treatment for Acute Exacerbation in Adult and Adolescent Participants With Asthma and Type 2 Inflammation

Last checked: Nov 20, 2026Latest source record: Sep 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 160 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

160

Actual

Start

Aug 8, 2025

Primary completion

Jul 17, 2026

Study completion Aug 10, 2026

Sponsor

Lead sponsor
Connect Biopharm LLCIndustry
Sponsor type
Industry
First posted
Apr 23, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase 2, randomized, multicenter study in adult and adolescent participants with asthma and type 2 inflammation

Conditions

  • Asthma Acute

Interventions

  • Rademikibart in prefilled syringeCombination product

    Participants receive 600 mg (4mL) of rademikibart administered subcutaneously.

  • Matching placebo in prefilled syringeDrug

    Participants receive 4mL of placebo matched to rademikibart administered subcutaneously.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Treatment failure rate within 28 days after randomizationTime frame: 28 days

Locations

58 sites in 6 countries. Site status is shown where the registry gives one.

  • Leland Stanford Junior University, Stanford Hospital

    Palo Alto, California

  • Amicis Research Center

    Valencia, California

  • Nemours Children's Hospital - DE

    Wilmington, Delaware

  • Nemours Children's Health

    Jacksonville, Florida

  • Pharmax Research of South Florida, Inc.

    Miami, Florida

  • Columbus Clinical Services, LLC

    Miami, Florida

  • Nemours Children's Health, Lake Nona

    Orlando, Florida

  • Health Synergy Clinical Research, LLC

    West Palm Beach, Florida

  • Primeway Clinical Research Group

    Fayetteville, Georgia

  • Pivotal Research Solutions

    Stonecrest, Georgia

  • University of Iowa

    Iowa City, Iowa

  • University of Kansas Medical Center

    Kansas City, Kansas

  • Allergy & Asthma Specialists, P.S.C.

    Owensboro, Kentucky

  • Chesapeake Clinical Research, Inc.

    White Marsh, Maryland

  • Washington University School of Medicine

    St Louis, Missouri

  • The Ohio State University Wexner Medical Center

    Columbus, Ohio

  • Clinical Research of Rock Hill

    Rock Hill, South Carolina

  • Inquest Clinical Research

    Baytown, Texas

  • Premier Pulmonary Critical Care and Sleep Medicine

    Denison, Texas

  • DCT- McAllen Primary Care Research, LLC dba Discovery Clinical Trials

    McAllen, Texas

  • Vermont Lung Center

    Colchester, Vermont

  • INSARES

    Mendoza, Argentina

  • Centro de Diagnostico y Rehabilitación S.A. -CEDIR

    Santa Fe, Argentina

  • STAT Research

    Caba, Buenos Aires, Argentina

  • Hospital Italiano de Buenos Aires

    Caba, Buenos Aires, Argentina

  • Investigaciones en Alergias y Enfermoedades Respiratorias (InAER)

    Caba, Buenos Aires, Argentina

  • Instituto Ave Pulmo-Fundacion Enfisema

    Mar del Plata, Buenos Aires, Argentina

  • Hospital Universitario Austral

    Pilar, Buenos Aires, Argentina

  • CEMER - Centro Medico de Enfermedades Respiratorias

    San Juan Bautista, Buenos Aires, Argentina

  • Centro respiratorio Infantil

    Rosario, Santa Fe Province, Argentina

  • INECO Neurociencias Oroño

    Rosario, Santa Fe Province, Argentina

  • Investigaciones en Patologias Respiratorias SRL

    San Miguel de Tucumán, Tucumán Province, Argentina

  • The Canberra Hospital

    Garran, Australian Capital Territory, Australia

  • Campbelltown Hospital

    Campbelltown, New South Wales, Australia

  • St. Vincent's Hospital Sydney

    Darlinghurst, New South Wales, Australia

  • St George Hospital, South Eastern Sydney Local Health District

    Kogarah, New South Wales, Australia

  • Queensland Children's Hospital

    South Brisbane, Queensland, Australia

  • Bendigo Health

    Bendigo, Victoria, Australia

  • JSC "National Center for Lung Health"

    Tbilisi, Georgia

  • LLC "Israel-Georgian Medical Research Clinic Healthycore"

    Tbilisi, Georgia

Showing 40 of 58 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.